Examples of 'fibrinolysis' in a sentence
Meaning of "fibrinolysis"
Fibrinolysis is a noun in medical terminology describing a process of breaking down blood clots
Show more definitions
- The process wherein a fibrin clot, the product of coagulation, is broken down.
How to use "fibrinolysis" in a sentence
Basic
Advanced
fibrinolysis
Fibrinolysis consists of activated plamin cleaving fibrin.
Plasmin initiates fibrinolysis by degrading fibrin.
Fibrinolysis is the process that destroys thrombi.
In all patients fibrinolysis was inhibited.
Fibrinolysis is the process of degradation of fibrin in the blood.
The degradation of fibrin is termed fibrinolysis.
Excessive fibrinolysis also causes continuous bleeding.
The breakdown of fibrin by plasmin is the basis of fibrinolysis.
It increases fibrinolysis the process by which clots dissolve.
This test is negative in primary fibrinolysis.
Fibrinolysis represents an other part of the protective mechanism.
The effect of neutrophil elastase on fibrinolysis is less ambiguous.
Fibrinolysis is the physiological mechanism that dissolves clots.
The thrombus may then disintegrate as a result of fibrinolysis.
Systemic fibrinolysis was discarded because of high risk of thrombus fragmentation.
See also
The activation of plasminogen is the central process in fibrinolysis.
The fibrinolysis system is responsible for removing blood clots.
A scheme of fibrin formation and fibrinolysis.
Impaired fibrinolysis is the result.
The other component of this potential antithrombotic activity is fibrinolysis.
Pathology of the fibrinolysis system.
Another body function that increases during a fast is fibrinolysis.
Markers of fibrinolysis and endothelial function in adult males with hemophilia.
The peptide should be used in an amount to promote fibrinolysis in vivo.
The needle aspiration and local fibrinolysis in surgery of intracranial hemorrhage.
The risk of bleeding is the major problem with fibrinolysis.
Fibrinolysis is the physiological breakdown of blood clots by enzymes such as plasmin.
Routine screening of blood coagulation and fibrinolysis revealed no abnormality.
Fibrinolysis inhibition by aminocaproic acid could theoretically result in clotting or thrombosis.
Fluid therapy and increased fibrinolysis may exaserbate this situation.
Fibrinolysis is the process of enzymatic dissolution of fibrinogen and fibrin clots.
Patients under fibrinolysis.
Developing fibrinolysis increases plasma loss and may cause secondary bleeding.
Not to be confused with fibrinolytic via fibrinolysis or the breakdown of fibrin.
The life span of a fibrin matrix is limited by the onset of fibrinolysis.
Detailed mechanisms as to fibrinolysis have been being revealed with the progress of biochemical researches.
This is called fibrinolysis.
A thrombus includes insoluble fibrin polymers that are later decomposed through fibrinolysis.
In this way the progression of fibrinolysis induced by MMPs can be assessed in situ.
The formation of an occlusive thrombus was associated with localised fibrinolysis defects.
The fibrin clot is degraded partly by fibrinolysis and partly by cellular phagocytosis.
Fibrin polymer can be degraded by means of the process called fibrinolysis.
The normal repair process allows for fibrinolysis alongside mesothelial repair.
This leads to the possibility to measure abnormalities in coagulation induced by aberrations in fibrinolysis.
This reaction is fibrinolysis.
Fibrinolysis is the process which causes an enzymatic dissolution of fibrinogen and fibrin clots.
Thus a TAFIa inibitor should serve to enhance the fibrinolysis cascade.
Abnormality of the coagulation fibrinolysis system is related to the origin of gestational toxicosis.
It acts as an inhibitor of fibrinolysis.
The balance of coagulation and fibrinolysis varies in accordance with underlying diseases or cases.
